Is Danaher (DHR) Offering Value After A 17.1% Year-To-Date Share Price Decline?

• If you are wondering whether Danaher at around US$191 a share represents fair value or a potential gap you can take advantage of, this article walks through what the numbers indicate about the stock today.
• The share price has returned 10.1% over the past year, even though the year-to-date return shows a 17.1% decline, which can change how investors view both its potential and its risks.
• Recent news coverage has focused less on short-term headlines and more on keeping Danaher on the radar for long-term investors. This helps frame the current price moves within a broader story and can be useful if you are trying to decide whether recent performance is an opportunity or a warning sign.
• Right now, Danaher has a valuation score of 3 out of 6. Next, you will see how traditional approaches such as P/E comparisons and discounted cash flow models assess the stock, followed by a way to think about valuation that goes a step further.

Find out why Danaher's 10.1% return over the last year is lagging behind its peers.

Approach 1: Danaher Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes the cash Danaher is expected to generate in the future, then discounts those amounts back to what they are worth in today’s dollars. It is essentially asking what a stream of future cash flows is worth right now.

For Danaher, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flows reported in $ and projected forward. The latest twelve month free cash flow is about $5.1b. Analyst inputs are used for the nearer years, then Simply Wall St extrapolates further out with projected free cash flow of $10.5b in 2035 according to the model’s ten year path.

When all these projected cash flows are discounted back to today, the DCF model estimates an intrinsic value of about $223.98 per share. Compared with the current share price of roughly $191, this implies the shares trade at a 14.7% discount to that estimate. On this cash flow view, Danaher appears to be trading below that modeled intrinsic value.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Danaher is undervalued by 14.7%. Track this in your watchlist or portfolio, or discover 61 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Danaher.

Approach 2: Danaher Price vs Earnings

For a profitable company like Danaher, the P/E ratio is a useful way to relate what you pay for each share to the earnings that share currently generates. In general, higher growth expectations and lower perceived risk tend to support a higher “normal” P/E, while slower growth or higher risk usually point to a lower fair range.

Danaher currently trades on a P/E of 37.55x. That sits above the Life Sciences industry average P/E of 32.55x and the peer group average of 30.01x. To go a step further, Simply Wall St calculates a proprietary “Fair Ratio” of 29.46x for Danaher. This Fair Ratio reflects factors such as earnings growth, industry, profit margins, market cap and identified risks, which makes it more tailored than a simple comparison to broad industry or peer averages.

When lined up against this Fair Ratio, Danaher’s current P/E of 37.55x is higher than the 29.46x estimate, which points to the shares trading above that modeled fair earnings multiple.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Danaher Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Think of a Narrative as the story you attach to Danaher that links your view of its business to a concrete forecast for revenue, earnings and margins. This then flows through to a fair value that you can compare with the current share price, all within an easy tool on Simply Wall St’s Community page. The tool updates when new earnings or news arrive and also shows how different investors can see the same stock very differently. For example, one Narrative might anchor on the bullish US$310 fair value, while another more cautious view might sit closer to US$220. This provides a clear range of perspectives to weigh against today’s price when deciding whether the stock appears attractive or expensive to you.

Do you think there's more to the story for Danaher? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com